SAMUEL COMPLETES SALE OF CERTAIN SERVICE CENTER ASSETS TO RUSSEL METALS
OAKVILLE, ON, Aug. 12, 2024 /PRNewswire/ – Samuel, Son & Co., Limited (Samuel), a leading metals distributor and industrial products manufacturer, announced... Read more.
RUSSEL METALS CLOSES ACQUISITION OF ASSETS FROM SAMUEL
TORONTO, Aug. 12, 2024 /PRNewswire/ – Russel Metals Inc. (TSX: RUS) announces that it has closed the acquisition of seven service centers located in Western... Read more.
Bit Digital, Inc. Announces Date for Second Quarter 2024 Financial Results and Conference Call
NEW YORK, Aug. 12, 2024 /PRNewswire/ — Bit Digital, Inc. (Nasdaq: BTBT) (“Bit Digital” or the “Company”), a sustainable platform for... Read more.
Yalla Group Limited Announces Unaudited Second Quarter 2024 Financial Results
DUBAI, UAE, Aug. 12, 2024 /PRNewswire/ — Yalla Group Limited (“Yalla” or the “Company”) (NYSE: YALA), the largest Middle East and North... Read more.
Biotech Innovations: Revolutionary Treatments Aim to Boost Pancreatic Cancer Survival Rates
USA News Group CommentaryIssued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, Aug. 12, 2024 /PRNewswire/ — USA News Group – Pancreatic cancer is among... Read more.
Leidos adds Curtiss-Wright to Alliance Partner Network
RESTON, Va., Aug. 12, 2024 /PRNewswire/ — Leidos (NYSE:LDOS), a FORTUNE® 500 innovation leader, today announced the addition of Curtiss-Wright, a global... Read more.
KBR Appoints Nchacha E. Etta to Board of Directors
HOUSTON, Aug. 12, 2024 /PRNewswire/ — KBR (NYSE: KBR) announced today the appointment of Nchacha E. Etta to its Board of Directors effective August 12, 2024.... Read more.
Accountable CRM Launches Activity-Based Software for Mortgage Teams
AUSTIN, Texas, Aug. 12, 2024 /PRNewswire/ — 90- Day Sales Manager proudly launches the first activity-based CRM with built-in coaching and accountability for... Read more.
Citius Pharmaceuticals Completes Merger of Subsidiary with TenX Keane to form Citius Oncology, Inc.
LYMPHIR™ for the treatment of cutaneous T-cell lymphoma approved by the FDA Citius Pharmaceuticals, Inc. holds approximately 90% of publicly traded Citius Oncology,... Read more.
ENOVA ANNOUNCES NEW $300 MILLION SHARE REPURCHASE PROGRAM
CHICAGO, Aug. 12, 2024 /PRNewswire/ — Enova International, Inc. (NYSE: ENVA) (“Enova” or the “Company”), a leading financial services... Read more.